Wearable tech monitors SMA babies at home to pinpoint best time for extra treatment
NCT ID NCT07543003
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows up to 60 babies with spinal muscular atrophy (SMA) found at birth, plus 30 healthy babies, for up to 30 months. Researchers use wearable devices worn at home to track muscle development and find when movements start to differ from normal. The goal is to identify the best time to give additional medicines that are being developed to support muscle strength.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINAL MUSCULAR ATROPHY (SMA) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Oxford
RECRUITINGOxford, OX3 9DU, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gene therapy hope for SMA kids: early trial launches
- New knee device may help kids with SMA build leg strength
- New VR device aims to make exercise fun for kids with muscle weakness
- Summer camp aims to boost strength in kids with SMA
- Can a support group boost confidence for parents of kids with DMD or SMA?
- Zolgensma's long-term effects under the microscope in new 5-year study